Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-04

FDA Approved: TISSUEBLUE — Supplemental Application (D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.)

View source ↗

Summary

FDA approved TissueBlue (Brilliant Blue G) as a supplemental application, granting its use as an ocular staining dye to assist cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TISSUEBLUE (Brilliant Blue G)

Snippet

SUPPL AP for TISSUEBLUE (BRILLIANT BLUE G)